Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D002417:Cattle; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007042:Hypoxanthines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007288:Inosine / Q000494:pharmacology*; D007291:Inosine Monophosphate / Q000494:pharmacology*; D007292:Inosine Nucleotides / Q000494:pharmacology*; D008297:Male; D009419:Nerve Tissue Proteins / Q000378:metabolism
D007042:Hypoxanthines; D007292:Inosine Nucleotides; D009419:Nerve Tissue Proteins; D007291:Inosine Monophosphate; D007288:Inosine; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006152:Cyclic GMP